Low-Frequency K103N Strengthens the Impact of Transmitted Drug Resistance on Virologic Responses to First-Line Efavirenz or Nevirapine-Based Highly Active Antiretroviral TherapyGERETTI, Anna Maria; FOX, Zoe V; BOOTH, Clare L et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 5, pp 569-573, issn 1525-4135, 5 p.Conference Paper

Pharmacokinetic drug interactions with nevirapineBACK, David; GIBBONS, Sara; KHOO, Saye et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, pp S8-S14, issn 1525-4135, SUP1Conference Paper

Efficacy and durability of Nevirapine in antiretroviral drug naïve patientsLANGE, Joep M. A.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, pp S40-S52, issn 1525-4135, SUP1Conference Paper

Impact of nevirapine on lipid metabolismCLOTET, Bonaventura; VAN DER VALK, Marc; NEGREDO, Eugenia et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, pp S79-S84, issn 1525-4135, SUP1Conference Paper

Evaluation of the Safety and Effectiveness of Nevirapine Plus Coformulated Tenofovir/Emtricitabine as First-Line Therapy in Routine Clinical PracticeVALLECILLO, Gabriel; DOMINGO, Pere; MALLOLAS, Josep et al.AIDS research and human retroviruses. 2012, Vol 28, Num 2, pp 165-170, issn 0889-2229, 6 p.Article

Comparative Outcomes of Tenofovir-Based and Zidovudine-Based Antiretroviral Therapy Regimens in Lusaka, ZambiaCHI, Benjamin H; MWANGO, Albert; STRINGER, Elizabeth M et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 5, pp 475-481, issn 1525-4135, 7 p.Article

Enzyme inducers reduce elimination half-life after a single dose of nevirapine in healthy womenL'HOMME, Rafaëlla F. A; DIJKEMA, Tim; VAN DER VEN, Andre J. A. M et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 2, pp 193-196, issn 1525-4135, 4 p.Article

Maternal toxicity with continuous nevirapine in pregnancy: Results from PACTG 1022HITTI, Jane; FRENKEL, Lisa M; GANDIA, Jorge et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 3, pp 772-776, issn 1525-4135, 5 p.Article

The Interaction of CD4 T-Cell Count and Nevirapine Hepatotoxicity in China: A Change in National Treatment Guidelines May Be WarrantedCHENGDA ZHANG; WEI WANG; TAISHENG LI et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 5, pp 540-545, issn 1525-4135, 6 p.Article

Detection of Nevirapine in plasma using thin-layer chromatographyDUBUISSON, Jeffrey G; KING, Jennifer R; STRINGER, Jeffrey S. A et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 35, Num 2, pp 155-157, issn 1525-4135, 3 p.Article

Stability of nevirapine suspension in prefilled oral syringes used for reduction of mother-to-child HIV transmissionREXROAD, Vivian E; PARSONS, Teresa L; HAMZEH, Fayez M et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 3, pp 373-375, issn 1525-4135, 3 p.Article

Serious adverse cutaneous and hepatic toxicities associated with Nevirapine use by non-hiv-lnfected individualsPATEL, Shilpa M; JOHNSON, Stuart; BELKNAP, Steven M et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 35, Num 2, pp 120-125, issn 1525-4135, 6 p.Article

The relationship between nevirapine plasma concentrations and abnormal liver function testsALMOND, Lisa M; BOFFITO, Marta; DI PERRI, Giovanni et al.AIDS research and human retroviruses. 2004, Vol 20, Num 7, pp 716-722, issn 0889-2229, 7 p.Article

Changes in nevirapine plasma concentrations over time and its relationship with liver enzyme elevationsGONZALEZ DE REQUENA, Daniel; JIMENEZ-NACHER, Inmaculada; SORIANO, Vincent et al.AIDS research and human retroviruses. 2005, Vol 21, Num 6, pp 555-559, issn 0889-2229, 5 p.Article

Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacyVAN LETH, F; KAPPELHOFF, B. S; WIT, F. W et al.AIDS research and human retroviruses. 2006, Vol 22, Num 3, pp 232-239, issn 0889-2229, 8 p.Article

Intrapartum Single-Dose Carbamazepine Reduces Nevirapine Levels Faster and May Decrease Resistance After a Single Dose of Nevirapine for Perinatal HIV PreventionMURO, Eva P; FILLEKES, Quirine; GIBB, Diana M et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 59, Num 3, pp 266-273, issn 1525-4135, 8 p.Article

Lipid Profiles in Young HIV-Infected Children Initiating and Changing Antiretroviral TherapySTREHLAU, Renate; COOVADIA, Ashraf; ABRAMS, Elaine J et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 4, pp 369-376, issn 1525-4135, 8 p.Article

Nevirapine for the Prevention of Mother-to-Child Transmission of HIV: A Nation-Wide Coverage Survey in Cote d'IvoireCOFFIE, Patrick A; KANHON, Serge K; TOURE, Hapsatou et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 57, issn 1525-4135, S3-S8, SUP1Article

Predictors of Rapid HIVTesting Acceptance and Successful Nevirapine Administration in Zambian Labor WardsMEGAZZINI, Karen M; CHINTU, Namwinga; VERMUND, Sten H et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 2, pp 273-279, issn 1525-4135, 7 p.Article

Lipodystrophy and dyslipidemia among patients taking first-line, world health organization-recommended highly active antiretroviral therapy regimens in western IndiaPUJARI, Sanjay N; DRAVID, Ameet; NAIK, Eknath et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 2, pp 199-202, issn 1525-4135, 4 p.Article

Associations With Virologic Treatment Failure in Adults on Antiretroviral Therapy in South AfricaMOHAMMED ISHAAQ DATAY; BOULLE, Andrew; MANT, David et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 5, pp 489-495, issn 1525-4135, 7 p.Article

Addition of Single-Dose Tenofovir and Emtricitabine to Intrapartum Nevirapine to Reduce Perinatal HIV TransmissionCHI, Benjamin H; CHINTU, Namwinga; CANTRELL, Ronald A et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 2, pp 220-223, issn 1525-4135, 4 p.Article

In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothersSCHRAMM, Diana B; KUHN, Louise; GRAY, Glenda E et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 42, Num 5, pp 545-553, issn 1525-4135, 9 p.Article

Reduction of mother-to-child transmission of HIV at saint camille medical centre in Burkina FasoSIMPORE, J; PIETRA, V; CASTELLI, F et al.Journal of medical virology. 2006, Vol 78, Num 2, pp 148-152, issn 0146-6615, 5 p.Article

Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012)ESHLEMAN, Susan H; GUAY, Laura A; MWATHA, Anthony et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 35, Num 2, pp 126-130, issn 1525-4135, 5 p.Article